<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Translating Pharmacological Findings from Hypothyroid Rodents to Euthyroid Humans: Is There a Functional Role of Endogenous 3,5-T2?</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Maik</forename><surname>Pietzner</surname></persName>
							<email>maik.pietzner@uni-greifswald.de</email>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry and Laboratory Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ina</forename><surname>Lehmphul</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute for Experimental Endocrinology</orgName>
								<orgName type="institution">Charite ´-University-Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nele</forename><surname>Friedrich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry and Laboratory Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Schurmann</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Interfaculty Institute for Genetics and Functional Genomics</orgName>
								<orgName type="institution">University Medicine and Ernst-Moritz-Arndt University Greifswald</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Till</forename><surname>Ittermann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Community Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcus</forename><surname>Do</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Internal Medicine B</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Nauck</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry and Laboratory Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rene</forename><surname>´laqua</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute for Diagnostic Radiology and Neuroradiology</orgName>
								<orgName type="institution">University Medicine Greifswald</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Uwe</forename><surname>Vo</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Interfaculty Institute for Genetics and Functional Genomics</orgName>
								<orgName type="institution">University Medicine and Ernst-Moritz-Arndt University Greifswald</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Brabant</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Medical Clinic I</orgName>
								<orgName type="institution">University of Lu ¨beck</orgName>
								<address>
									<addrLine>Lu ¨beck</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Henry</forename><surname>Vo</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Community Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Josef</forename><surname>Ko</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute for Experimental Endocrinology</orgName>
								<orgName type="institution">Charite ´-University-Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Homuth</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Interfaculty Institute for Genetics and Functional Genomics</orgName>
								<orgName type="institution">University Medicine and Ernst-Moritz-Arndt University Greifswald</orgName>
								<address>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Henri</forename><surname>Wallaschofski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Clinical Chemistry and Laboratory Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dipl</forename><surname>Biomath</surname></persName>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Institute for Clinical Chemistry and Laboratory Medicine</orgName>
								<orgName type="institution">University Medicine Greifswald Ferdinand-Sauerbruch-Straße</orgName>
								<address>
									<postCode>D-17475</postCode>
									<settlement>Greifswald</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Translating Pharmacological Findings from Hypothyroid Rodents to Euthyroid Humans: Is There a Functional Role of Endogenous 3,5-T2?</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">C681CCD43A69C936943AF90F3FA29043</idno>
					<idno type="DOI">10.1089/thy.2014.0262</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: During the last two decades, it has become obvious that 3,5-diiodothyronine (3,5-T2), a wellknown endogenous metabolite of the thyroid hormones thyroxine (T4) or triiodothyronine (T3), not only represents a simple degradation intermediate of the former but also exhibits specific metabolic activities.</s><s>Administration of 3,5-T2 to hypothyroid rodents rapidly stimulated their basal metabolic rate, prevented highfat diet-induced obesity as well as steatosis, and increased oxidation of long-chain fatty acids.</s><s>Objective: The aim of the present study was to analyze associations between circulating 3,5-T2 in human serum and different epidemiological parameters, including age, sex, or smoking, as well as measures of anthropometry, glucose, and lipid metabolism.</s><s>Methods: 3,5-T2 concentrations were measured by a recently developed immunoassay in sera of 761 euthyroid participants of the population-based Study of Health in Pomerania.</s><s>Subsequently, analysis of variance and multivariate linear regression analysis were performed.</s><s>Results: Serum 3,5-T2 concentrations exhibited a right-skewed distribution, resulting in a median serum concentration of 0.24 nM (1st quartile: 0.20 nM; 3rd quartile: 0.37 nM).</s><s>Significant associations between 3,5-T2 and serum fasting glucose, thyrotropin (TSH), as well as leptin concentrations were detected ( p &lt; 0.05).</s><s>Interestingly, the association to leptin concentrations seemed to be mediated by TSH.</s><s>Age, sex, smoking, and blood lipid profile parameters did not show significant associations with circulating 3,5-T2.</s><s>Conclusion: Our findings from a healthy euthyroid population may point toward a physiological link between circulating 3,5-T2 and glucose metabolism.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>D espite first descriptions of the metabolic effects of 3,5-diiodothyronine (3,5-T2) <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2)</ref>, it was considered as a physiologically inactive metabolite of the two major thyroid hormones (TH) thyroxine (T4) and triiodothyronine (T3).</s><s>Recent pharmacological applications of 3,5-T2 mainly in hypothyroid rodent models <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4)</ref> challenged this hypothesis because they revealed rapid and chronic metabolic changes, partly independent of the classical T3 receptors (TR).</s><s>3,5-T2 rapidly enhanced hepatic oxygen consumption <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>, and hepatic mitochondria were identified as specific targets <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b7">8)</ref>.</s><s>Moreover, 3,5-T2 was suggested to influence glucose me-tabolism by stimulating glucose-6-phosphate dehydrogenase (G6PD) activity <ref type="bibr" target="#b8">(9)</ref> or by modulating gluconeogenesis via sirtuin 1 <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b10">11)</ref>.</s><s>Moreno et al. <ref type="bibr" target="#b5">(6)</ref> reported a complementary effect of 3,5-T2 to T3 on stimulating the resting metabolic rate in rats.</s><s>Furthermore, administered in pharmacological doses, 3,5-T2 prevented rodents from weight gain from a high-fat diet <ref type="bibr" target="#b11">(12)</ref> and restrained the development of insulin resistance <ref type="bibr" target="#b9">(10)</ref>.</s><s>Possible discussed underlying mechanisms included the activation of thermogenesis <ref type="bibr" target="#b12">(13)</ref>, the prevention of fat accumulation in skeletal muscle as well as in the liver <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b13">14)</ref>, and the enhancement of lipolysis <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13)</ref>, together resulting in remarkable antisteatotic effects under high-fat diet conditions.</s></p><p><s>In comparison, knowledge about the role of 3,5-T2 in human metabolism is sparse.</s><s>Following the development of 3,5-T2 radioimmunoassays (RIAs), age-and sex-specific differences in serum 3,5-T2 concentrations <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref> as well as associations with chronic renal diseases, liver cirrhosis, and sepsis were reported <ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref>.</s><s>Nevertheless, a validation of many of those associations in larger studies is lacking.</s></p><p><s>Expanding these initial findings and questioning former results that reported a wide spectrum of serum 3,5-T2 concentrations over almost two orders of magnitude in rather small groups of analyzed individuals, we now used a newly developed assay <ref type="bibr" target="#b19">(20)</ref> to determine serum 3,5-T2 concentrations in a larger healthy study population.</s><s>The aim of the present study was to analyze associations between serum 3,5-T2 concentrations and metabolic parameters from glucose and lipid metabolism as well as anthropometric measures in a euthyroid population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>The Study of Health in Pomerania (TREND) (SHIP-TREND) is a second cohort of a population-based research project in West Pomerania, a rural region in northeast Germany <ref type="bibr" target="#b20">(21)</ref>.</s><s>A stratified random sample of 8826 adults aged 20-79 years was drawn from population registries.</s><s>Sample selection was facilitated by centralization of local population registries in the Federal State of Mecklenburg-West Pomerania.</s><s>Stratification variables were age, sex, and city/county of residence.</s><s>Baseline examinations were conducted between 2008 and 2012.</s><s>Out of all invitations, 4420 choose to participate (50.1% response).</s><s>All participants gave written informed consent.</s><s>The study was approved by the local ethics committee and conformed to the principles of the declaration of Helsinki.</s><s>SHIP data are publically available for scientific and quality control purposes.</s><s>Data usage can be applied for via www.community-medicine.de.</s></p><p><s>The present study population comprises a subsample of 1001 subjects without self-reported diabetes.</s><s>Of the 1001 participants, 108 subjects with missing data for serum 3,5-T2 concentrations were excluded.</s><s>Furthermore, 132 subjects with at least one of the following conditions (overlap exists) were excluded: use of thyroid medications (ATC code H03A, n = 94), serum thyrotropin (TSH) levels outside the reference range (0.30-3.59 mIU/L, n = 54), missing values in investigated parameters (n = 5), or serum 3,5-T2 concentrations differing more than two times the standard deviation from the mean concentration ( &gt; 2.13 nM, n = 10).</s><s>The final study population (euthyroid sample) available for the present analysis comprised 761 subjects (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>For 666 subjects, whole-body magnetic resonance imaging (MRI) data were available, whereas vaspin and leptin serum levels were determined for 712 and 744 participants respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurements</head><p><s>Each SHIP-TREND participant underwent standardized medical examinations, blood sampling, and an extensive computer-aided personal interview.</s><s>Data on sociodemographic characteristics and medical histories were collected.</s><s>During the physical examination, standardized measurements of body weight and height were performed with calibrated scales.</s><s>Body mass index (BMI) was calculated as weight (kg)/height 2 (m 2 ).</s><s>Waist circumference (WC) was measured using an inelastic tape while the participant stood securely with weight equally distributed on both feet.</s><s>The measurement relies on the circumference between the lower rib margin and the iliac crest in the horizontal plane.</s><s>Based on these measurements, the waist-to-height ratio (WHtR) was calculated as WC (cm)/ height (cm).</s></p><p><s>Whole body magnetic resonance imaging (MRI) was performed on a commercial 1.5-Tesla system (Magnetom Avanto; Siemens Healthcare AG, Erlangen, Germany; software version Syngo MR B15) using a body phased array coil.</s><s>The quantification of subcutaneous and visceral fat was done using the automatic tissue and labeling analysis software ATLAS and in-house developed software from the University of Ulm <ref type="bibr" target="#b21">(22)</ref>.</s><s>Afterwards, manual correction by certified students was applied.</s></p><p><s>Fasting blood samples (fasting ‡ 8 h) were drawn between 6:00am and 7:00pm from the cubital vein of subjects in the supine position and analyzed immediately or stored at -80°C.</s><s>Serum TSH concentrations were measured using an immunoassay (Dimension VISTA; Siemens Healthcare Diagnostics, Eschborn, Germany) with a functional sensitivity of 0.005 mIU/L.</s><s>Total cholesterol, total triglyceride, and serum glucose concentrations were measured by photometry (Dimension VISTA; Siemens Healthcare Diagnostics).</s><s>High- density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol were selectively precipitated and then determined by homogenous assays (Dimension VISTA, Siemens Healthcare Diagnostics).</s><s>Serum vaspin (AdipoGen, Liestal, Switzerland) and leptin (Mediagnost, Reutlingen, Germany) concentrations were measured using the enzymelinked immunosorbent assay (ELISA) technique.</s><s>Glycated hemoglobin (HbA1c) was determined by high-performance liquid chromatography (Bio-Rad, Munich, Germany).</s></p><p><s>Insulin serum concentrations were measured using a chemiluminescent immunometric assay (Immulite 200 XPi; Siemens Healthcare Diagnostics) with a functional sensitivity of 2 lIU/mL.</s><s>The homeostatic model of insulin resistance (HOMA-IR) was calculated as insulin (lIU/mL) • glucose (mmol/L)/22.5 according to Matthews et al. <ref type="bibr" target="#b22">(23)</ref>.</s></p><p><s>Serum 3,5-T2 concentrations were measured with a recently developed monoclonal antibody-based chemiluminescence immunoassay <ref type="bibr" target="#b19">(20)</ref>.</s><s>Blood samples were stored for about five years prior to analysis.</s><s>In the course of assay validation <ref type="bibr" target="#b19">(20)</ref>, different storage conditions, that is, room temperature, 4°C and -20°C, as well as several freeze-thaw cycles did not disturb 3,5-T2 stability, leading to the assumption that even prolonged storage would not affect the results.</s><s>The functional sensitivity of the assay was specified as 0.2 nM.</s><s>The interassay variation was between 5.6% and 12.9%.</s><s>The working range was declared as 0.2-10 nM 3,5-T2.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Continuous data are expressed as median (1st, 3rd quartile); nominal data are expressed as percentages.</s><s>For bivariate statistics, the Kruskal-Wallis test (continuous data) or the chi-square test (nominal data) were used to compare men and women.</s><s>In a pre-analysis step, we compared participants below (n = 274) and above (n = 487) 0.2 nM, with respect to age, sex, and smoking.</s><s>As there were no significant differences (data not shown), we decided to continue without stratification regarding 3,5-T2 as outcome.</s><s>In a first step, we tested the influence of age using 10-year age groups, sex, and smoking on serum 3,5-T2 concentrations.</s><s>Boxplots were used to visualize the distribution of serum 3,5-T2 concentrations.</s><s>Values below the detection limit (0.2 nM) were stratified as follows: (a) values distinct from zero but &lt; 0.1 nM were set to 0.05 nM as the lowest point of the standard curve, or (b) values &gt; 0.1 nM were set to 0.2 nM.</s><s>Kruskal-Wallis tests were used to detect overall significance and Wilcoxon rank-sum tests to test for group differences.</s><s>In a second step, two types of linear regression analysis were performed.</s><s>First, mean values of the considered markers for anthropometry, glucose, or lipid metabolism with confidence intervals (CI) depending on 3,5-T2 concentration were calculated by age-and sex-adjusted analysis of variance (AN-OVA).</s><s>For this purpose, three distinct groups of participants were defined according to their serum 3,5-T2 concentrations: &lt; 0.2 nM (n = 274) but distinct from zero, 0.2-0.33 nM (n = 243), and &gt; 0.33 nM (n = 244).</s><s>Second, multivariate linear regression analysis was performed with 3,5-T2 as continuous independent variable, including age and sex as covariates, thereby excluding all participants with values below the detection limit of the assay (n = 487).</s><s>As ANOVA results indicated possible nonlinear trends, restricted cubic splines with three equidistant knots (5th, 50 th , and 95th per-centile) were used to detect possible nonlinear associations <ref type="bibr" target="#b23">(24)</ref>.</s><s>The additional spline variable was only included if it led to a significant increase in model fitness assessed by a likelihood ratio test.</s><s>Dependent variables were log-transformed to achieve a normal distribution if necessary.</s><s>The number of subjects depended on the used outcome variable as shown in Figure <ref type="figure" target="#fig_0">1</ref>.</s></p><p><s>To observe whether an altered thyroid state would affect the presented results, all analyses were also performed on the whole sample, only excluding participants with missing values in variables under investigation (n = 888; n = 315 with values &lt; 0.2 nM but distinct from zero).</s></p><p><s>A p-value of &lt; 0.05 was considered statistically significant.</s><s>Statistical analyses were performed using SAS v9.3 (SAS Institute, Inc., Cary, NC) and R v3.0.1 <ref type="bibr" target="#b24">(25)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>General characteristics for men and women are displayed in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Women had lower values of BMI, WC, WHtR, and visceral fat, whereas the amount of subcutaneous fat as well as vaspin and leptin concentrations were higher compared to men.</s><s>Furthermore, women exhibited more favorable lipid profiles (higher HDL, lower LDL, and lower total triglycerides) as well as more advantageous glycemic profiles (lower serum glucose, HbA1c, and HOMA-IR) and smoking behavior.</s></p><p><s>Concerning serum 3,5-T2 concentrations, no sex-specific differences were apparent (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The median serum 3,5-T2 concentration amounted to 0.24 nM (1st quartile: 0.20 nM; 3rd quartile: 0.37 nM).</s><s>In addition, neither age nor smoking were significantly associated with serum 3,5-T2 concentrations (Fig. <ref type="figure">2</ref>).</s><s>Adjusted ANOVA revealed a partly positive association between TSH and 3,5-T2, where subjects with serum 3,5-T2 concentrations &lt; 0.  <ref type="table" target="#tab_0">S1</ref>; Supplementary Data are available online at www .liebertpub.com/thy).</s><s>In contrast, further increasing serum 3,5-T2 concentrations were inversely associated with TSH concentrations as indicated by linear regression analysis (Fig. <ref type="figure">3</ref> and Table <ref type="table">2</ref>).</s></p><p><s>Subsequently, we analyzed 3,5-T2 concentrations in relation to anthropometric measures, including BMI, WC, and WHtR, as well as the amount of visceral and subcutaneous fat (Fig. <ref type="figure">3</ref>).</s><s>All measures except subcutaneous fat demonstrated similar-shaped variations in the means between the three defined 3,5-T2 groups, indicating a nonlinear trend.</s><s>However, none of them displayed a significant nonlinear behavior in linear regression analyses on the subsample with serum 3,5-T2 concentrations &gt; 0.2 nM.</s></p><p><s>Association analyses by adjusted ANOVA with several parameters of glucose metabolism revealed a significant positive correlation between fasting glucose and 3,5-T2, while HbA1c, insulin concentrations, and HOMA-IR were also slightly positively correlated but did not reach statistical significance (Fig. <ref type="figure">4</ref>).</s><s>For glucose, an estimated mean value of 5.49 mmol/L [CI 5.42-5.56]</s><s>was found for the group with high serum 3,5-T2 concentrations, while the remaining groups exhibited values of about 5.35 mmol/L (Fig. <ref type="figure">4</ref> and Supplementary Table <ref type="table">S2</ref>).</s><s>Interestingly, linear regression analyses on the subsample with 3,5-T2 serum concentrations &gt; 0.2 nM revealed a significant bell-shaped association, confirming AN-OVA results up to a peak at 0.5 nM (Fig. <ref type="figure">4</ref> and Table <ref type="table">2</ref>).</s></p><p><s>Adjusted mean concentrations of parameters for lipid metabolism remained stable along the 3,5-T2 groups.</s><s>The exception were slightly lower HDL cholesterol concentrations in subjects with low serum 3,5-T2 concentrations but without reaching statistical significance (Fig. <ref type="figure" target="#fig_3">5</ref> and Table <ref type="table">2</ref>).</s><s>Finally, regarding adipokines, adjusted ANOVA revealed that subjects with intermediate serum 3,5-T2 concentrations exhibited significantly higher concentrations of leptin compared to those with low serum 3,5-T2 concentrations, indicating a nonlinear association.</s><s>As discussed below, this relation was probably mediated by TSH, since further adjustment for serum TSH concentrations leads to a loss of association between leptin and 3,5-T2.</s></p><p><s>Neither adjusted ANOVA nor linear regression analysis revealed sustainable differences in association patterns between the whole or euthyroid sample.</s><s>The association between 3,5-T2 and TSH was, however, more pronounced in the whole sample, as can be seen from linear regression analysis (Fig. <ref type="figure">3</ref> and Table <ref type="table">2</ref>), which further indicates an exponential decline in mean TSH concentrations for serum 3,5-T2 concentrations &gt; 0.2 nM.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>To the best of our knowledge, this is the first focused analysis of a large euthyroid study population that specifically investigates associations between serum 3,5-T2 concentrations and several metabolic characteristics, including anthropometric and glucose and lipid metabolism measurements.</s><s>For this purpose, we used a newly developed immunoassay <ref type="bibr" target="#b19">(20)</ref>, representing the only currently available method to determine serum 3,5-T2 concentrations in humans <ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>.</s><s>Our data revealed significant bell-shaped associations of serum 3,5-T2 concentrations with serum glucose concentration and TSH concentrations in the fasting state, pointing toward a versatile role of circulating 3,5-T2 in human metabolism.</s><s>In contrast, markers for blood lipid profile and anthropometry seemed to be effected by TSH itself or unaffected respectively.</s></p><p><s>Compared with results reported in previous studies on euthyroid humans, we measured markedly higher median serum 3,5-T2 concentration <ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref><ref type="bibr" target="#b16">(17)</ref><ref type="bibr" target="#b17">(18)</ref><ref type="bibr" target="#b18">(19)</ref><ref type="bibr" target="#b28">(29)</ref><ref type="bibr" target="#b29">(30)</ref><ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b32">(32)</ref><ref type="bibr" target="#b33">(33)</ref>.</s><s>One possible explanation might be the brief incubation time of almost one hour in most polyclonal antibody-based RIAs compared with the overnight incubation performed in our monoclonal antibody immunoassay.</s><s>Furthermore, previously reported age- <ref type="bibr" target="#b15">(16)</ref> or sex-related (15) differences in serum 3,5-T2 concentrations were not confirmed by the present analyses.</s><s>The small sample sizes of the former studies including 81 <ref type="bibr" target="#b15">(16)</ref> or 52 <ref type="bibr" target="#b14">(15)</ref> subjects might be the most likely reason.</s><s>With respect to TSH, a bellshaped trend along the 3,5-T2 groups was observed, which was more pronounced when participants with subclinical thyroid disease were included (Fig. <ref type="figure">3</ref> and Table <ref type="table">2</ref>).</s><s>In particular, this link is in accordance with animal studies showing that 3,5-T2 was only a third as potent as T3 in suppressing TSH concentrations, and rather high pharmacological 3,5-T2 concentrations are required for TSH suppression <ref type="bibr" target="#b34">(34)</ref><ref type="bibr" target="#b35">(35)</ref><ref type="bibr" target="#b37">(36)</ref>.</s><s>However, several animal studies in rodents and other species, for example killifish, indicated that 3,5-T2 interferes with the hypothalamus-pituitary-thyroid axis at several levels such as pituitary, thyroid, and peripheral action, thereby displaying a broad spectrum of mechanisms involved such as classical interaction with TR and also rapid effects at the cell membrane and mitochondria <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b34">(34)</ref><ref type="bibr" target="#b35">(35)</ref><ref type="bibr" target="#b37">(36)</ref><ref type="bibr" target="#b38">(37)</ref><ref type="bibr" target="#b39">(38)</ref><ref type="bibr" target="#b40">(39)</ref><ref type="bibr" target="#b41">(40)</ref> (for a review, see ( <ref type="formula">3</ref>)).</s><s>Action of 3,5-T2 via these different targets and molecular mechanisms might occur at different 3,5-T2 concentrations and depend on acute or chronic exposure <ref type="bibr" target="#b35">(35,</ref><ref type="bibr" target="#b38">37,</ref><ref type="bibr" target="#b41">40)</ref>, thus possibly explaining the unexpected bell-shaped relationship with serum TSH.</s></p><p><s>Adjusted ANOVA revealed a positive correlation between fasting glucose and low to intermediate serum 3,5-T2 concentrations.</s><s>Of note, several other relevant parameters including serum insulin, HOMA-IR, and HbA1c also exhibited similar trends toward a positive relation, although their associations with serum 3,5-T2 concentrations did not reach statistical significance.</s><s>In concordance, a study on obese women <ref type="bibr" target="#b42">(41)</ref>, who fasted for four days, reported a rise in serum 3,5-T2 concentrations after glucose ingestion.</s><s>Challenging this trend in categorical analysis, continuous splines indicated an inverse association in mean glucose concentrations at serum 3,5-T2 concentrations &gt; 0.5 nM (Fig. <ref type="figure">4</ref>).</s><s>This observation is in line with a 3,5-T2-mediated increase in glucose sensitivity described for pharmacological interventions with high doses of 3,5-T2 in animal models <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b10">11)</ref>.</s><s>A possible indication to understand this discrepancy could be an effect of 3-iodothyronamine, which was suggested as a degradation product of 3,5-T2 and exhibited hyperglycemic effects <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b43">42)</ref>.</s><s>An antagonistic link between these two TH FIG. <ref type="figure">3</ref>. Comparison between the whole and the euthyroid subsample.</s><s>Top: Estimated mean levels of thyrotropin (TSH) and anthropometric markers with 95% confidence intervals by serum 3,5-diiodothyronine concentrations calculated by analysis of variance adjusted for age and sex.</s><s>p whole and p eut , p-values from analysis of variance (ANOVA) about an overall difference between groups in the whole and euthyroid sample, respectively.</s><s>Significant differences between groups were marked for comparison with the { lowest and { intermediate (p &lt; 0.05).</s><s>Bottom: Predicted mean values of the same parameters conditioned on 3,5-diiodothyronine serum concentrations &gt; 0.2 nM for a 50-year-old man from linear regression analysis.</s><s>Corresponding p-values are listed in Table <ref type="table">2</ref>.  derivatives could be contributing to the observed nonlinear associations.</s><s>Furthermore, one could argue that the observed associations might be mediated by the classical metabolic active T3 (or T4), since a recent study on euthyroid humans provided evidence for interference between T3 and fasting serum glucose <ref type="bibr" target="#b44">(43)</ref>.</s><s>Depending on a previously published reference range for TSH concentrations that referred to our study region (0.25-2.12 mIU/L) ( <ref type="formula">44</ref> obvious (Supplementary Table <ref type="table">S2</ref>), further supporting an independent effect of 3,5-T2 on glucose metabolism.</s><s>This finding is also in agreement with our previous study, where no correlation between 3,5-T2 and serum T4 and T3 concentrations was observed in healthy or T4-substituted individuals (20).</s><s>However, since early experimental work suggested an extrathyroidal conversion of 3,5-T2 from T3 also in humans <ref type="bibr" target="#b46">(45)</ref>, the missing correlation observed within our tight subset does not necessarily exclude a physiological link between both, and further effort is needed for clarification.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Comparison in Linear Regression</head><p><s>Even leptin concentrations exhibited a nonlinear association with serum 3,5-T2 concentrations, whereby the highest mean leptin concentrations were observed for individuals with intermediate serum 3,5-T2 concentrations.</s><s>Interdependency between serum leptin and TH concentrations is assumed to be mediated by a complex interplay with TSH, further involving thyrotropin-releasing hormone <ref type="bibr" target="#b47">(46,</ref><ref type="bibr" target="#b48">47)</ref>.</s><s>In concordance, a recent study on young men provided evidence for a link between serum TSH and leptin concentrations, even in the euthyroid state <ref type="bibr" target="#b49">(48)</ref>.</s><s>In recognition of these results, we tested for a possible effect of TSH on the association between 3,5-T2 and leptin.</s><s>Indeed, further adjustment in ANOVA led to a loss of significance, thereby strengthening the dependency between serum TSH and leptin concentrations, as well as the relation between circulating TSH and 3,5-T2.</s><s>In conclusion, further work is needed to elucidate the roles of circulating 3,5-T2 and leptin in TH homeostasis.</s></p><p><s>According to the promising effects of pharmacological interventions with 3,5-T2 on body weight or blood lipid profile <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b50">49)</ref>, missing associations toward related measures require a clarifying note.</s><s>To ensure an effect on resting metabolic rate, most of the studies used a daily intraperitoneal injection of 25 lg 3,5-T2 per 100 g body weight <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b13">14)</ref>, and rather high doses were needed for oral administration in humans and rodents <ref type="bibr" target="#b50">(49,</ref><ref type="bibr" target="#b51">50)</ref>.</s><s>In detail, a chronic treatment with 3,5-T2 at doses of up to 900 lg per day led to a significant weight loss in one human study <ref type="bibr" target="#b50">(49)</ref>, a 3,5-T2 dose ninefold higher than average daily thyroidal production of T4, the putative precursor of 3,5-T2, which is only a minor metabolite of T4 according to previous kinetic studies <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s>Therefore, a dose-dependent effect could be reasonable, exceeding endogenous 3,5-T2 concentrations by far and pronouncing selected 3,5-T2 mediated effects.</s><s>This might include for example a stimulatory effect on TH receptor b (39), which was attributed to enhance b-oxidation of long-chain fatty acids <ref type="bibr" target="#b47">(46)</ref>, a key mechanism for weight loss.</s><s>Beside dose-dependent effects, when administered in comparable doses, 3,5-T2 was shown to act rapidly and complementary to T3 on resting metabolic rate (51), the major contributor to weight maintenance.</s><s>Taking into account such moderate effects on anthropometry and/or lipid metabolism by 3,5-T2, the application of more sensitive clinical markers as provided by metabolomics could possibly validate reported associations <ref type="bibr" target="#b53">(52)</ref>.</s></p><p><s>It has to be emphasized that all detected associations observed in our study, even when reaching statistical significance, were relatively weak.</s><s>Hence, consequences for clinical practice cannot necessarily be expected.</s><s>Since our study is cross-sectional, there are several limitations, especially in comparison to investigations on 3,5-T2 action using animal models.</s><s>Most of these represent longitudinal studies on hypothyroid phenotypes including interventions by 3,5-T2 administration.</s><s>In contrast, cross-sectional studies are limited in their prediction of time courses and intervention effects.</s><s>In addition, the present study was performed in euthyroid humans.</s><s>Therefore, the role of 3,5-T2 in thyroid diseases could not be delineated and requires separate analyses of appropriate patient cohorts.</s><s>Moreover, nearly a third of study participants (n = 274) exhibited serum 3,5-T2 concentrations below the functional sensitivity defined as limit of detection of the used assay, thereby limiting statistical analyses.</s></p><p><s>In conclusion, using a recently developed immunoassay, we were able to determine serum 3,5-T2 concentrations in a relatively large euthyroid study population and to test for associations with anthropometric and metabolic parameters.</s><s>Our data point toward a physiological link between 3,5-T2 and glucose metabolism as well as TH homeostasis, while no significant associations with age, sex, and smoking or parameters of blood lipid profile and anthropometric measures were observed.</s><s>Further analyses on even larger samples of euthyroid individuals, as well as pharmacological intervention studies, are needed to confirm the detected associations and to detect possible more moderate effects in order to obtain a more comprehensive picture of the role of 3,5-T2 in human metabolism.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG. 1 .</head><label>1</label><figDesc><div><p><s>FIG. 1. Flowchart representing the steps for study compilation.</s><s>Numbers in parentheses indicate the respective data for the whole sample.</s><s>*n = 423 and **n = 492 subjects for continuous analysis.</s></p></div></figDesc><graphic coords="2,311.41,59.75,238.02,320.37" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>2 nM exhibited lower adjusted mean TSH concentrations (1.09 [CI 1.03-1.15])</s><s>compared to subjects with intermediate serum 3,5-T2 concentrations (1.20 [CI 1.13-1.28];</s><s>Fig. 3 and Supplementary Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Analyses Between All Participants with 3,5-T2 Serum Concentrations &gt; 0.2 nM (Whole) and a Euthyroid Subpopulation</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG. 5 .</head><label>5</label><figDesc><div><p><s>FIG. 4.Comparison between the whole and the euthyroid subsample.</s><s>Top: Estimated mean levels of serum glucose, HbA1c, HOMA-IR, and insulin with 95% confidence intervals by serum 3,5-diiodothyronine concentrations calculated by ANOVA adjusted for age and sex.</s><s>p whole and p eut , p-values from ANOVA about an overall difference between groups in the whole and euthyroid sample, respectively.</s><s>Significant differences between groups were marked for comparison with the { lowest and { intermediate ( p &lt; 0.05).</s><s>Bottom: Predicted mean level of the same parameters conditioned on 3,5-diiodothyronine serum concentrations &gt; 0.2 nM for a 50-year-old man from linear regression analysis.</s><s>Corresponding p-values are listed in Table2.</s><s>HOMA-IR, homeostatic model of insulin resistance; HbA1c, glycosylated hemoglobin.</s></p></div></figDesc><graphic coords="7,126.82,59.75,360.93,221.95" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,59.75,579.29,336.92,156.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="5,67.92,59.75,478.48,190.38" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>General Characteristics of the Study Population</s></p></div></figDesc><table><row><cell>Characteristics</cell><cell>Male (n = 358)</cell><cell>Female (n = 403)</cell><cell>p*</cell></row><row><cell>Age, years</cell><cell>50 (38; 60)</cell><cell>49 (40; 59)</cell><cell>0.79</cell></row><row><cell>Smoking, %</cell><cell></cell><cell></cell><cell>&lt; 0.01</cell></row><row><cell>Never smoker</cell><cell>32.0</cell><cell>52.7</cell><cell></cell></row><row><cell>Former smoker</cell><cell>43.4</cell><cell>27.1</cell><cell></cell></row><row><cell>Current smoker</cell><cell>24.6</cell><cell>20.2</cell><cell></cell></row><row><cell>TSH, mIU/L Body mass index, kg/m 2</cell><cell>1.13 (0.80; 1.47) 27.7 (25.0; 30.3)</cell><cell>1.27 (0.90; 1.75) 26.2 (23.1; 30.0)</cell><cell>&lt; 0.01 &lt; 0.01</cell></row><row><cell>Waist circumference, cm</cell><cell>94.0 (86.0; 102.0)</cell><cell>81.5 (73.5; 90.1)</cell><cell>&lt; 0.01</cell></row><row><cell>Waist-to-height ratio</cell><cell>0.53 (0.48; 0.58)</cell><cell>0.50 (0.45; 0.55)</cell><cell>&lt; 0.01</cell></row><row><cell>Visceral fat, L</cell><cell>4.70 (2.75; 7.02)</cell><cell>2.40 (1.14; 3.66)</cell><cell>&lt; 0.01</cell></row><row><cell>Subcutaneous fat, L</cell><cell>6.13 (4.58; 8.06)</cell><cell>7.99 (6.10; 11.11)</cell><cell>&lt; 0.01</cell></row><row><cell>HDL cholesterol, mmol/L</cell><cell>1.28 (1.10; 1.47)</cell><cell>1.59 (1.34; 1.87)</cell><cell>&lt; 0.01</cell></row><row><cell>LDL cholesterol, mmol/L</cell><cell>3.41 (2.78; 4.00)</cell><cell>3.33 (2.70; 3.95)</cell><cell>0.44</cell></row><row><cell>Total cholesterol, mmol/L</cell><cell>5.3 (4.6; 6.1)</cell><cell>5.5 (4.9; 6.2)</cell><cell>0.01</cell></row><row><cell>Total triglycerides, mmol/L</cell><cell>1.28 (0.91; 1.95)</cell><cell>1.12 (0.84; 1.56)</cell><cell>&lt; 0.01</cell></row><row><cell>Vaspin, ng/mL</cell><cell>0.47 (0.26; 0.76)</cell><cell>0.76 (0.47; 1.46)</cell><cell>&lt; 0.01</cell></row><row><cell>Leptin, ng/mL</cell><cell>6.1 (3.5; 9.4)</cell><cell>18.1 (11.3; 29.5)</cell><cell>&lt; 0.01</cell></row><row><cell>Serum glucose, mmol/L</cell><cell>5.4 (5.1; 5.8)</cell><cell>5.2 (4.9; 5.6)</cell><cell>&lt; 0.01</cell></row><row><cell>HbA1c, %</cell><cell>5.2 (4.9; 5.6)</cell><cell>5.1 (4.8; 5.5)</cell><cell>&lt; 0.01</cell></row><row><cell>HOMA-IR</cell><cell>0.64 (0.47; 1.37)</cell><cell>0.54 (0.45; 1.26)</cell><cell>&lt; 0.01</cell></row><row><cell>Insulin, lIU/mL</cell><cell>2.6 (2.0; 5.3)</cell><cell>2.3 (2.0; 5.1)</cell><cell>0.27</cell></row><row><cell>3,5-Diiodothyronine, nM</cell><cell></cell><cell></cell><cell></cell></row><row><cell>20-29 years (m = 39, f = 31)</cell><cell>0.20 (0.20; 0.31)</cell><cell>0.22 (0.20; 0.40)</cell><cell>0.40</cell></row><row><cell>30-39 years (m = 57, f = 64)</cell><cell>0.21 (0.20; 0.41)</cell><cell>0.25 (0.20; 0.39)</cell><cell>0.35</cell></row><row><cell>40-49 years (m = 81, f = 111)</cell><cell>0.27 (0.20; 0.40)</cell><cell>0.25 (0.20; 0.35)</cell><cell>0.67</cell></row><row><cell>50-59 years (m = 83, f = 99)</cell><cell>0.30 (0.20; 0.43)</cell><cell>0.23 (0.20; 0.32)</cell><cell>0.07</cell></row><row><cell>60-69 years (m = 64, f = 69)</cell><cell>0.26 (0.20; 0.35)</cell><cell>0.23 (0.20; 0.36)</cell><cell>0.55</cell></row><row><cell>70 + years (m = 34, f = 29)</cell><cell>0.22 (0.20; 0.34)</cell><cell>0.29 (0.21; 0.40)</cell><cell>0.08</cell></row><row><cell>Overall</cell><cell>0.24 (0.20; 0.38)</cell><cell>0.24 (0.20; 0.37)</cell><cell>0.94</cell></row><row><cell cols="3">Continuous data are expressed as median (25th; 75th); nominal data are given as percentages.</cell><cell></cell></row><row><cell cols="3">*Chi-square test (nominal data) or Kruskal-Wallis test (interval data) were used for comparison.</cell><cell></cell></row><row><cell cols="4">HDL, high-density lipoprotein; LDL, low-density lipoprotein; TSH, thyrotropin; HOMA-IR, homeostatic model assessment of insulin</cell></row><row><cell>resistance; HbA1c, glycosylated hemoglobin.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>Multivariate linear regression model adjusted for age and sex; **additional variable if 3,5-T2 concentrations were modeled by means of restricted cubic splines (appears only when the usage of splines represented a gain in model quality assessed by a likelihood ratio test).</s></p></div></figDesc><table><row><cell>-</cell><cell>-</cell><cell>-</cell><cell>-0.31] 0.03</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell></cell></row><row><cell>-</cell><cell>-</cell><cell>-</cell><cell>-7.89,</cell><cell>-</cell><cell>-</cell><cell>-</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>-4.10 [</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0.31</cell><cell>0.10</cell><cell>0.64</cell><cell>0.03</cell><cell>0.23</cell><cell>0.85</cell><cell>0.81</cell><cell></cell></row><row><cell>-0.08 [ -0.24, 0.07]</cell><cell>0.28 [ -0.06, 0.62]</cell><cell>-0.05 [ -0.28, 0.17]</cell><cell>0.82 [0.08, 1.57]</cell><cell>-0.12 [ -0.31, 0.08]</cell><cell>0.02 [ -0.21, 0.25]</cell><cell>-0.03 [ -0.29, 0.23]</cell><cell></cell></row><row><cell>11, 0.03] 0.26 --487</cell><cell>Vaspin, ng/dL Yes 536 0.08 [ -0.06, 0.23] 0.27 --454</cell><cell>Leptin, ng/dL Yes 561 0.02 [ -0.07, 0.12] 0.66 --475</cell><cell>Serum glucose, mmol/L No 573 0.46 [0.01, 0.91] 0.05 -1.40 [ -2.56, -0.23] 0.02 487</cell><cell>-487 HbA1c, % No 573 0.004 [ -0.077, 0.086] 0.92 -</cell><cell>-487 HOMA-IR Yes 573 0.001 [ -0.098, 0.100] 0.98 -</cell><cell>-269 Insulin, lIU/mL Yes 313 0.10 [ -0.06, 0.27] 0.22 -</cell><cell>Log-scale indicates whether the dependent variable was transformed by natural logarithm before analysis.</cell></row></table><note><p><s>*</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="3">,5-T2 AND GLUCOSE/FAT METABOLISM</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="190">PIETZNER ET AL.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="3">,5-T2 AND GLUCOSE/FAT METABOLISM</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="192">PIETZNER ET AL.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="194">PIETZNER ET AL.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="3">,5-T2 AND GLUCOSE/FAT METABOLISM</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>This work was funded by grants from the German Federal Ministry of Education and Research (BMBF, Grants 01ZZ0403, 01ZZ0103, 01GI0883), the Ministry for Education, Research and Cultural Affairs, and the Ministry of Social Affairs of the Federal State of Mecklenburg-West Pomerania.</s><s>This work is also part of the research project Greifswald Approach to Individualized Medicine (GA-NI_MED).</s><s>The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A).</s><s>The project was conducted within the framework of the DFG SPP 1692 ''Thyroid Trans Act'' (DFG WA 1328/5-1, KO 922/17-1 and VO 955/12-1) and the DFG GRK 1208-2 (TP 3 to J.K.).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Disclosure Statement</head><p><s>The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Eigenschaften und biologische Wirkungen von Derivaten (A ¨thern) des Thyroxins, Dijodthyronins und Dijodtyrosins</title>
		<author>
			<persName><forename type="first">A</forename><surname>Loeser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ruland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Trikojus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Naunyn Schmiedebergs Arch Pharmacol</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="664" to="678" />
			<date type="published" when="1938">1938 Darstellung</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Effects of thyroxine, 3,5-diiodothyronine and thyronine on ascorbic acid oxidation</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Gemmill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="349" to="354" />
			<date type="published" when="1951">1951</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Metabolic effects of thyroid hormone derivatives</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="239" to="253" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Thyronamines-past, present, and future</title>
		<author>
			<persName><forename type="first">S</forename><surname>Piehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hoefig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scanlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ko ¨hrle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="64" to="80" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Effect of 3,3¢-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cioffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="143" to="148" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">How the thyroid controls metabolism in the rat: different roles for triiodothyronine and diiodothyronines</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Physiol</title>
		<imprint>
			<biblScope unit="volume">505</biblScope>
			<biblScope unit="page" from="529" to="538" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">In vitro binding of 3,5-di-iodo-L-thyronine to rat liver mitochondria</title>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Horst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thoma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="275" to="282" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3¢-diiodo-L-thyronine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Endocrinol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="89" to="94" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">,5-Diiodo-Lthyronine regulates glucose-6-phosphate dehydrogenase activity in the rat</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beneduce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Diano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Colantuoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Ursini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="1729" to="1734" />
			<date>2000 3</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-L-thyronine in rats</title>
		<author>
			<persName><forename type="first">P</forename><surname>De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cioffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Senese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Matteis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lionetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mollica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="2730" to="2739" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">5-Diiodo-L-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats</title>
		<author>
			<persName><forename type="first">G</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="674" to="684" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">,5-Diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ragni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Farina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Baccari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fallahi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1552" to="1554" />
			<date>2005 3</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Busiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Endocrinol Metabol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="E497" to="E502" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Matteis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>De Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Glinni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Senese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cioffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Salzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Scaloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="3312" to="3324" />
			<date>2011 3</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A radioimmunoassay of serum 3,5-diiodothyronine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Faber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siersbaek-Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Friis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Endocrinol (Copenh)</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="196" to="201" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Age-related changes of serum 3,3¢-diiodothyronine, 3¢,5¢-diiodothyronine, and 3,5-diiodothyronine concentrations in man</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Naito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mashio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Imura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metabol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="517" to="522" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Simultaneous turnover studies of thyroxine, 3,5,3¢-and 3,3¢,5¢-triiodothyronine, 3,5-,3,3¢-, and 3¢,5¢-diiodothyronine, and 3¢-monoiodothyronine in chronic renal failure</title>
		<author>
			<persName><forename type="first">J</forename><surname>Faber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lumholtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siersbaek-Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kollendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Friis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="211" to="217" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The extrathyroidal conversion of 3,5,3¢-triiodothyronine to 3,5-diiodothyronine in patients with liver cirrhosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Faber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lumholtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siersbaek-Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Friis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="428" to="431" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meinhold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hiedra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hoell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Stoltenburg-Didinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Eravci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prengel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Brodel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Finke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baumgartner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="1535" to="1542" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay</title>
		<author>
			<persName><forename type="first">I</forename><surname>Lehmphul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brabant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallaschofski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruchala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Strasburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kohrle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1350" to="1360" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Vo ¨lzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">O</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Radke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lorbeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Aumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piontek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Born</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Havemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ittermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schipf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Haring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Baumeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wallaschofski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Frick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ju ¨nger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mayerle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kraft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Lerch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Do ¨rr M, Reffelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Empen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Felix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Obst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gla ¨ser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ewert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fietze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Penzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Do ¨ren M, Rathmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Haerting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hannemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ro ¨pcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schminke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ju ¨rgens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rettig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ungerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hegenscheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-P</forename><surname>Ku ¨hn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ku ¨hn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hosten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Puls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Henke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Gloger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Teumer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Homuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Vo ¨lker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schwahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Holtfreter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Polzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Grabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rosskopf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Kroemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Biffar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="294" to="307" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Cohort profile: the study of health in Pomerania</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Quantification of human body fat tissue percentage by MRI</title>
		<author>
			<persName><forename type="first">H-P</forename><surname>Mu ¨ller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Raudies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Unrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Ludolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kassubek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NMR Biomed</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="17" to="24" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hosker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Rudenski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Naylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Treacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Turner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="412" to="419" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Additive splines in statistics</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-Y</forename><surname>Koo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Stat Comp Sect Am Statist Assoc</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="45" to="48" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">R: A Language and Environment for Statistical Computing 3.0.1. R Foundation for Statistical Computing</title>
		<imprint>
			<date type="published" when="2013">2013</date>
			<pubPlace>Vienna, Austria</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates</title>
		<author>
			<persName><forename type="first">S</forename><surname>Piehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heberer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Balizs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Scanlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ko ¨hrle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rapid Commun Mass Spectrom</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="3286" to="3296" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stapleton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal Bioanal Chem</title>
		<imprint>
			<biblScope unit="volume">397</biblScope>
			<biblScope unit="page" from="1831" to="1839" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Differentiation of diiodothyronines using electrospray ionization tandem mass spectrometry</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Conrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thoma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Conrad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mass Spectrom</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="162" to="168" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A radioimmunoassay for 3,5-diiodothyronine</title>
		<author>
			<persName><forename type="first">H</forename><surname>Meinhold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schurnbrand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Endocrinol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="493" to="497" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A radioimmunoassay for measurement of 3,5-diiodothyronine</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Maciel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Chopra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ozawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Geola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Solomon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="399" to="405" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Pangaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Burman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wartofsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Cahnmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Smallridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>O'brian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Latham</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Radioimmunoassay for 3,5-diiodothyronine and evidence for dependence on conversion from 3,5,3¢-triiodothyronine</title>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1075" to="1081" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Serum concentrations of 3,3¢-diiodothyronine, 3¢,5¢-diiodothyronine, and 3,5-diiodothyronine in altered thyroid states</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Naito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mashio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Imura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinol Jpn</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">167</biblScope>
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The deiodination of the iodothyronines and of their derivatives in man</title>
		<author>
			<persName><forename type="first">D</forename><surname>Engler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Burger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="151" to="184" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sokolov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Endocrinol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="137" to="147" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">-Diiodo-Lthyronine stimulates type 1 5¢ deiodinase activity in rat 196</title>
		<author>
			<persName><forename type="first">A</forename><surname>Baur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jarry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Ko ¨hrle</surname></persName>
		</author>
		<author>
			<persName><surname>Pietzner</surname></persName>
		</author>
		<author>
			<persName><surname>Al</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">3</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro</title>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="3242" to="3248" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">5-Di-iodo-Lthyronine suppresses TSH in rats in vivo and in rat pituitary fragments in vitro</title>
		<author>
			<persName><forename type="first">C</forename><surname>Horst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Harneit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Seitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rokos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="291" to="297" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">5-Diiodothyronine in vivo maintains euthyroidal expression of type 2 iodothyronine deiodinase, growth hormone, and thyroid hormone receptor beta1 in the killifish</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lopez-Bojorquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nunez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Valverde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Orozco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="R877" to="883" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">5-T2 stimulates oxygen consumption, but not glucose uptake in human mononuclear blood cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kvetny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="322" to="325" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">5-T2 is an alternative ligand for the thyroid hormone receptor beta1</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mendoza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Navarrete-Ramirez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hernandez-Puga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Villalobos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Holzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Renaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Laudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Orozco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="2948" to="2958" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">,5-diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Mollica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lionetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Antonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cavaliere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Barletta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="363" to="370" />
			<date>2009 3</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3¢-and 3¢-5¢-diiodothyronine and 3¢-monoiodothyronine</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jaedig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Faber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Endocrinol (Copenh)</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="388" to="392" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Detection of 3-iodothyronamine in human patients: a preliminary study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Galli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Berti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tonacchera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vitti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Scanlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Iervasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zucchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="E69" to="74" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Roef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Rietzschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Van Daele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E</forename><surname>Taes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Buyzere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gillebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="223" to="231" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Reference intervals of serum thyroid function tests in a previously iodine-deficient area</title>
		<author>
			<persName><forename type="first">H</forename><surname>Vo ¨lzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Alte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu ¨demann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nauck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Meng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="279" to="285" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Simultaneous measurement of 3,5-diiodothyronine and 3,5,3¢-triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects</title>
		<author>
			<persName><forename type="first">J</forename><surname>Faber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">B</forename><surname>Lumholtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siersbaek-Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Friis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="8" to="12" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Thyroid hormone regulation of metabolism</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mullur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Brent</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="355" to="382" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Thyroid hormone and obesity</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Pearce</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Endocrinol Diabetes Obes</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="408" to="413" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men</title>
		<author>
			<persName><forename type="first">G</forename><surname>Roef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lapauw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goemaere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Zmierczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Toye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kaufman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Taes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="719" to="726" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects</title>
		<author>
			<persName><forename type="first">A</forename><surname>Antonelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fallahi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Domenicantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Regul Homeost Agents</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="655" to="660" />
			<date>2010 3</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Goldberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Huggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Nagareddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Scanlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Ehrenkranz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="5143" to="5149" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Are the effects of T3 on resting metabolic rate in euthyroid rats entirely caused by T3 itself?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beneduce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silvestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pinna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="504" to="510" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Opening up the &apos;&apos;Black Box&apos;&apos;: metabolic phenotyping and metabolome-wide association studies in epidemiology</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bictash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Ebbels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Iks</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Iorio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Daviglus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stamler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Nicholson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Elliott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="970" to="979" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
